InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.650
-0.030 (-1.79%)
Oct 6, 2026, 9:57 AM EDT - Market open
InflaRx Employees
InflaRx had 65 employees as of December 31, 2025. The number of employees decreased by 9 or -12.16% compared to the previous year.
Employees
65
Change (1Y)
-9
Growth (1Y)
-12.16%
Revenue / Employee
n/a
Profits / Employee
-$688,021
Market Cap
243.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 65 | -9 | -12.16% |
| Dec 31, 2024 | 74 | 12 | 18.97% |
| Dec 31, 2023 | 62 | 18 | 40.41% |
| Dec 31, 2022 | 44 | -12 | -20.75% |
| Dec 31, 2021 | 56 | 9 | 18.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Sutro Biopharma | 128 |
| Invivyd | 122 |
| Alector | 103 |
| Lineage Cell Therapeutics | 77 |
| Camp4 Therapeutics | 48 |
| Sol-Gel Technologies | 28 |
| Q32 Bio | 22 |
IFRX News
- 4 days ago - InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026 - GlobeNewsWire
- 5 days ago - InflaRx appoints Alperovich as SVP, Global Head of Clinical Development - TheFly
- 5 days ago - InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development - GlobeNewsWire
- 15 days ago - InflaRx to Host Virtual Capital Markets Day - GlobeNewsWire
- 21 days ago - InflaRx Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 22 days ago - InflaRx initiated with a Buy at Needham - TheFly
- 26 days ago - InflaRx Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 weeks ago - InflaRx Announces Participation in September Investor Conferences - GlobeNewsWire